Katrien Lemmens

1.9k total citations
33 papers, 1.5k citations indexed

About

Katrien Lemmens is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Katrien Lemmens has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 13 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Katrien Lemmens's work include CAR-T cell therapy research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Cardiac Fibrosis and Remodeling (5 papers). Katrien Lemmens is often cited by papers focused on CAR-T cell therapy research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Cardiac Fibrosis and Remodeling (5 papers). Katrien Lemmens collaborates with scholars based in Belgium, United States and France. Katrien Lemmens's co-authors include Gilles W. De Keulenaer, Kris Doggen, Vincent F. M. Segers, Guido R.Y. De Meyer, Marc Demolder, Andreas B. Gevaert, Christiaan Vrints, Hadis Shakeri, Emeline M. Van Craenenbroeck and Arthur Leloup and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.

In The Last Decade

Katrien Lemmens

31 papers receiving 1.4k citations

Peers

Katrien Lemmens

CCM

ONCOL

PHYSI

SURGE

Toshihiro Tsuruda Japan

Atsushi Ogino Japan

Anna Mazzeo Italy

Johan Duchêne Germany

Laura Calvillo Italy

Hind Lal United States

Fumihiro Sanada Japan

Noriko Makita Japan

Kari Ylitalo Finland

David Gregg United States

Toshihiro Tsuruda Japan

Katrien Lemmens

806 ×1.1

CCM

822 ×1.7

251 ×0.7

ONCOL

232 ×1.1

PHYSI

372 ×2.3

SURGE

Citations per year, relative to Katrien Lemmens Katrien Lemmens (= 1×) peers Toshihiro Tsuruda

Countries citing papers authored by Katrien Lemmens

Since Specialization

Citations

This map shows the geographic impact of Katrien Lemmens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrien Lemmens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrien Lemmens more than expected).

Fields of papers citing papers by Katrien Lemmens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrien Lemmens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrien Lemmens. The network helps show where Katrien Lemmens may publish in the future.

Co-authorship network of co-authors of Katrien Lemmens

This figure shows the co-authorship network connecting the top 25 collaborators of Katrien Lemmens. A scholar is included among the top collaborators of Katrien Lemmens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrien Lemmens. Katrien Lemmens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garciaz, Sylvain, Pierre Péterlin, Daniel Morillo, et al.. (2025). γ9δ2 T-cell (γ9δ2TC) activation with ICT01 and azacitidine-venetoclax (Aza-Ven) induces high rates of remission and overall survival in patients with newly diagnosed (ND) acute myeloid leukemia (AML): Results from the phase 1/2 study eviction. Blood. 146(Supplement 1). 652–652.

Maiti, Abhishek, Pierre Péterlin, Daniel Morillo, et al.. (2024). ICT01, an Investigational γ9δ2 T Cell Activator, Added to Azacitidine-Venetoclax Achieves Frequent and Early Complete Remissions in Adults with AML Unfit for Intensive Induction Chemotherapy: Interim Results from the Ongoing Open-Label, Randomized Phase 1 Study Eviction. Blood. 144(Supplement 1). 2876–2876. 1 indexed citations

Champiat, Stéphane, Martin Wermke, Cécile Vicier, et al.. (2024). EVICTION study: ICT01, an anti-Butyrophilin 3A monoclonal antibody activating γ9δ2 T cells in combination with pembrolizumab in checkpoint inhibitor refractory melanoma.. Journal of Clinical Oncology. 42(16_suppl). 9534–9534. 2 indexed citations

Garciaz, Sylvain, Stéphane Champiat, Pierre Péterlin, et al.. (2023). 822O Activation of γ9δ2 T cells by ICT01 as a novel immunotherapeutic approach for relapsed/refractory hematologic cancers (EVICTION trial). Annals of Oncology. 34. S543–S543. 2 indexed citations

Bono, Johann S. de, Stéphane Champiat, François‐Xavier Danlos, et al.. (2023). Abstract CT179: First-in-human study of ICT01, an anti-BTN3A activating monoclonal antibody in combination with low dose IL-2 in patients with advanced solid tumors (EVICTION-2 study). Cancer Research. 83(8_Supplement). CT179–CT179. 1 indexed citations

Bono, Johann S. de, Stéphane Champiat, François‐Xavier Danlos, et al.. (2023). 715 ICT01 plus low dose SC IL-2 produces a robust anti-tumor immune activation in advanced cancer patients (EVICTION-2 Study). SHILAP Revista de lepidopterología. A810–A810. 3 indexed citations

Shakeri, Hadis, Andreas B. Gevaert, D. Schrijvers, et al.. (2018). Neuregulin-1 attenuates stress-induced vascular senescence. Cardiovascular Research. 114(7). 1041–1051. 40 indexed citations

Gevaert, Andreas B., Katrien Lemmens, Christiaan Vrints, & Emeline M. Van Craenenbroeck. (2017). Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training. Oxidative Medicine and Cellular Longevity. 2017(1). 4865756–4865756. 48 indexed citations

Bruyndonckx, Luc, Vicky Y. Hoymans, Katrien Lemmens, José Ramet, & Christiaan Vrints. (2016). Childhood obesity–related endothelial dysfunction: an update on pathophysiological mechanisms and diagnostic advancements. Pediatric Research. 79(6). 831–837. 33 indexed citations

10.

Roth, Lynn, Miche Rombouts, D. Schrijvers, et al.. (2015). Chronic intermittent mental stress promotes atherosclerotic plaque vulnerability, myocardial infarction and sudden death in mice. Atherosclerosis. 242(1). 288–294. 36 indexed citations

11.

Fransen, Paul, Cor E. Van Hove, Arthur Leloup, et al.. (2015). Dissecting out the Complex Ca2+-Mediated Phenylephrine-Induced Contractions of Mouse Aortic Segments. PLoS ONE. 10(3). e0121634–e0121634. 48 indexed citations

12.

Roth, Lynn, Debby Van Dam, Carole Van der Donckt, et al.. (2014). Impaired gait pattern as a sensitive tool to assess hypoxic brain damage in a novel mouse model of atherosclerotic plaque rupture. Physiology & Behavior. 139. 397–402. 15 indexed citations

13.

Doggen, Kris, Paul Fransen, Katrien Lemmens, & Gilles W. De Keulenaer. (2011). Effects of Nebivolol on Vascular Endothelial and Myocardial Function in Diabetes Mellitus. Journal of Cardiovascular Pharmacology. 58(1). 56–64. 6 indexed citations

14.

Lemmens, Katrien, Kris Doggen, & Gilles W. De Keulenaer. (2010). Activation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy. American Journal of Physiology-Heart and Circulatory Physiology. 300(3). H931–H942. 63 indexed citations

15.

Doggen, Kris, et al.. (2008). Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure. Journal of Molecular and Cellular Cardiology. 46(1). 33–38. 26 indexed citations

16.

Lemmens, Katrien, Kris Doggen, & Gilles W. De Keulenaer. (2008). Neuregulin-1 and its potential role in the control of cardiac function.. PubMed. 5(4). 119–24. 5 indexed citations

17.

Lemmens, Katrien, et al.. (2006). Endogenous Inhibitors of Hypertrophy in Concentric Versus Eccentric Hypertrophy. European Journal of Heart Failure. 9(4). 352–356. 11 indexed citations

18.

Lemmens, Katrien, Vincent F. M. Segers, Marc Demolder, & Gilles W. De Keulenaer. (2006). Role of Neuregulin-1/ErbB2 Signaling in Endothelium-Cardiomyocyte Cross-talk. Journal of Biological Chemistry. 281(28). 19469–19477. 141 indexed citations

19.

Segers, Vincent F. M., Katrien Lemmens, Jan Hendrickx, Stanislas U. Sys, & Gilles W. De Keulenaer. (2005). Inhibition of heme oxygenase?1 impairs cardiac muscle sensitivity to beta?adrenergic stimulation. Basic Research in Cardiology. 100(3). 224–230. 4 indexed citations

20.

Segers, Vincent F. M., Ivan Van Riet, Luc Andries, et al.. (2005). Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms. American Journal of Physiology-Heart and Circulatory Physiology. 290(4). H1370–H1377. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact